# Global pharmaceutical and oncology market growth projections > Live situation record from CLSTR: https://clstr.news/situations/global-pharmaceutical-market-growth-projections > Updated: 2026-09-11T01:03:56.000Z. Sources: 7. Developments: 5. The global pharmaceutical and oncology markets are projected to experience substantial growth through the early 2030s, driven by innovative therapies and advancements in diagnostics. While total pharmaceutical spending is expected to exceed $2.6 trillion by 2030, specialized oncology sectors are seeing even more rapid expansion. In the oncology segment, the hematologic cancer therapeutics market is forecasted to grow from $74.6 billion in 2025 to $138.8 billion by 2032. This sector remains highly concentrated, with the top ten companies expected to account for approximately 81% of sales in 2025. Further specialized growth is noted in the gamma delta T cell cancer therapy market, which is projected to reach $4.94 billion by 2030 with a compound annual growth rate (CAGR) of 18.4%, and the thyroid cancer drug market, which is expected to reach $2.39 billion by 2030. Diagnostic and intervention markets are also expanding. The global cancer diagnostics market is expected to reach $44.69 billion by 2030, while the histology market is projected to rise from $8.9 billion in 2026 to $14.5 billion by 2031. Additionally, the hematopoietic stem cell transplantation market is forecasted to reach $8.57 billion by 2030. Beyond oncology, the peripheral vascular intervention product market is expected to grow from approximately $81.7 billion in 2025 to $131.18 billion by 2032, driven by aging populations and increased prevalence of vascular diseases. ## Claims - The cancer diagnostics market is expected to grow at a CAGR of 11.8% between 2026 and 2030. (corroborated by 2 sources) - AI-driven oncology diagnostics and next-generation sequencing are key drivers for the cancer diagnostics market. (corroborated by 2 sources) - UK total healthcare expenditure in 2023 increased by 5.6% in nominal terms compared to 2022. (corroborated by 2 sources) - The cancer diagnostics market is projected to reach $44.69 billion by 2030, representing a CAGR of 11.8% from 2026. (corroborated by 2 sources) - Investment in AI-driven oncology diagnostics and next-generation sequencing is driving growth in the cancer diagnostics market. (corroborated by 2 sources) - UK total healthcare expenditure increased by 5.6% in 2023 compared to 2022. (corroborated by 2 sources) - The breast cancer drugs market is projected to reach $61.19 billion by 2030, with a CAGR of 7.8%. (single source) - Breast cancer accounts for approximately 30% of new cancer cases among women in the United States. (single source) - Breast cancer accounts for approximately 30% of all new cancer cases among women in the United States. (single source) ## Timeline ### 2026-09-11: Global cancer therapy markets projected to grow significantly by 2030 Global cancer therapy markets are expanding, with gamma delta T cell treatments projected to reach $4.94 billion and thyroid cancer drugs to reach $2.39 billion by 2030. 2 sources. https://clstr.news/cluster/global-cancer-therapy-markets-projected-to-grow-significantly-by-2030 ### 2026-09-08: Global medical markets for oncology and vascular therapies projected to grow Global markets for hematologic oncology drugs, stem cell transplants, histology, and vascular interventions are projected to grow significantly through 2032. 5 sources. https://clstr.news/cluster/hematologic-cancer-drug-market-projected-to-reach-1388-billion-by-2032 ### 2026-09-08: Cancer diagnostics and breast cancer drug markets projected to grow through 2030 Global cancer diagnostics and breast cancer drug markets are projected to see significant growth through 2030, driven by AI, precision medicine, and rising healthcare spending. 3 sources. https://clstr.news/cluster/cancer-diagnostics-and-breast-cancer-drug-markets-projected-for-significant-growth-through-2030 ### 2026-08-27: Global pharmaceutical market growth projected to reach $2.6 trillion by 2030 A study by IQVIA predicts global pharmaceutical spending will exceed $2.6 trillion by 2030, driven by oncology, immunology, diabetes, and obesity treatments, with China seeing rapid growth. 2 sources. https://clstr.news/cluster/global-pharmaceutical-market-growth-projected-to-reach-26-trillion-by-2030 ### 2026-08-13: Generic oncology drug market projected to reach $39.99 billion by 2030 The global generic oncology drug market is expected to reach nearly $40 billion by 2030, fueled by rising cancer rates and patent expirations of major brand-name treatments. 2 sources. https://clstr.news/cluster/generic-oncology-drug-market-projected-to-reach-3999-billion-by-2030 --- Cite as: Global pharmaceutical and oncology market growth projections. CLSTR, https://clstr.news/situations/global-pharmaceutical-market-growth-projections